Although patients seem to crave more data on their disease and prognosis, they may not be understanding what their oncologists tell them, research suggests. One oncologist reflects on why this gap may exist.
The treatment of advanced bladder cancer may be lagging behind that of other cancers, but experts suggest that genomic profiling may provide key insights into patient care.
The phase II ROCKET trial, which was temporarily halted after three patient deaths, has started up again. The trial is testing a new compound, JCAR015, to treat adults with B cell acute lymphoblastic leukemia.
A new study found that radiologists can come to vastly different conclusions about breast density based on mammograms.
The Exome Cancer Test v1.0 (EXaCT-1) has found 21,000 cancer-driving mutations, according to this recent analysis.
This weekly news roundup is brought to our readers by our partners at Cancer Network and OncoTherapy Network, which are a part of UBM Medica. (Free registration is required.)
The Expectation Gap: Oncotherapy Network & Cancer Network
Aucun commentaire:
Enregistrer un commentaire